Skip to content
10-Q

Quarterly Report

LIPOSCIENCE INC

0001168197-14-000055

← back to feed
Filed
Nov 12, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2014 · Nov 7, 2014 15.35M sh
Capex Q3 2014 · Sep 30, 2014 $4.53M
Capex Q3 2014 · Sep 30, 2013 $2.94M
Long Term Debt Q3 2014 · Sep 30, 2014 $11.96M
Long Term Debt Q3 2014 · Dec 31, 2013 $0
Short Term Debt Q3 2014 · Sep 30, 2014 $3.9M
Short Term Debt Q3 2014 · Dec 31, 2013 $0
Cash And Equivalents Q3 2014 · Sep 30, 2014 $40M
Cash And Equivalents Q3 2014 · Dec 31, 2013 $49.57M
Cash And Equivalents Q3 2014 · Sep 30, 2013 $51.57M
Cash And Equivalents Q3 2014 · Dec 31, 2012 $24.77M
Stockholders Equity Q3 2014 · Sep 30, 2014 $38.71M
Stockholders Equity Q3 2014 · Dec 31, 2013 $47.76M
Current Liabilities Q3 2014 · Sep 30, 2014 $9.48M
Current Liabilities Q3 2014 · Dec 31, 2013 $21.61M
Total Liabilities Q3 2014 · Sep 30, 2014 $23.99M
Total Liabilities Q3 2014 · Dec 31, 2013 $24.24M
Current Assets Q3 2014 · Sep 30, 2014 $44.78M
Current Assets Q3 2014 · Dec 31, 2013 $56.59M
Total Assets Q3 2014 · Sep 30, 2014 $62.7M
Total Assets Q3 2014 · Dec 31, 2013 $72M
Sga Expense Q3 2014 · Sep 30, 2014 $3.54M
Sga Expense Q3 2014 · Sep 30, 2014 $10.07M
Sga Expense Q3 2014 · Sep 30, 2013 $3.3M
Sga Expense Q3 2014 · Sep 30, 2013 $9.38M
Rd Expense Q3 2014 · Sep 30, 2014 $2.01M
Rd Expense Q3 2014 · Sep 30, 2014 $6.63M
Rd Expense Q3 2014 · Sep 30, 2013 $3.39M
Rd Expense Q3 2014 · Sep 30, 2013 $9.64M
Net Income Q3 2014 · Sep 30, 2014 −$4.26M
Net Income Q3 2014 · Sep 30, 2014 −$10.36M
Net Income Q3 2014 · Sep 30, 2013 −$4.63M
Net Income Q3 2014 · Sep 30, 2013 −$9.92M
Operating Income Q3 2014 · Sep 30, 2014 −$3.83M
Operating Income Q3 2014 · Sep 30, 2014 −$9.07M
Operating Income Q3 2014 · Sep 30, 2013 −$4.18M
Operating Income Q3 2014 · Sep 30, 2013 −$8.51M
Gross Profit Q3 2014 · Sep 30, 2014 $6.29M
Gross Profit Q3 2014 · Sep 30, 2014 $22.27M
Gross Profit Q3 2014 · Sep 30, 2013 $10.13M
Gross Profit Q3 2014 · Sep 30, 2013 $31.59M